Meca-Lallana, J., Prieto González, J. M., Caminero Rodríguez, A., Olascoaga Urtaza, J., Alonso, A., Durán Ferreras, E., . . . Llarena, C. (2023). Effectiveness and Safety of Teriflunomide in Relapsing-Remitting Multiple Sclerosis and Improvements in Quality of Life: Results from the Real-World TERICARE Study.
Citación estilo ChicagoMeca-Lallana, J.E., et al. Effectiveness and Safety of Teriflunomide in Relapsing-Remitting Multiple Sclerosis and Improvements in Quality of Life: Results From the Real-World TERICARE Study. 2023.
Cita MLAMeca-Lallana, J.E., et al. Effectiveness and Safety of Teriflunomide in Relapsing-Remitting Multiple Sclerosis and Improvements in Quality of Life: Results From the Real-World TERICARE Study. 2023.
Precaución: Estas citas no son 100% exactas.